VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $515 | -4.8% | 57,843 | +8.4% | 0.00% | – |
Q1 2024 | $541 | -38.0% | 53,379 | -38.4% | 0.00% | – |
Q4 2023 | $872 | -60.6% | 86,604 | -63.3% | 0.00% | – |
Q3 2023 | $2,212 | -88.8% | 235,927 | -70.6% | 0.00% | -100.0% |
Q2 2023 | $19,674 | +118.5% | 802,034 | +107.3% | 0.00% | +200.0% |
Q1 2023 | $9,005 | -7.7% | 386,945 | +0.3% | 0.00% | -50.0% |
Q4 2022 | $9,761 | -99.9% | 385,648 | +0.0% | 0.00% | +100.0% |
Q3 2022 | $7,436,000 | +65.4% | 385,609 | +118.4% | 0.00% | 0.0% |
Q2 2022 | $4,496,000 | -61.2% | 176,539 | -60.8% | 0.00% | 0.0% |
Q1 2022 | $11,583,000 | -53.7% | 450,363 | -24.6% | 0.00% | -50.0% |
Q4 2021 | $25,015,000 | +1474.3% | 597,433 | +1536.0% | 0.00% | – |
Q3 2021 | $1,589,000 | -55.7% | 36,519 | -51.9% | 0.00% | – |
Q2 2021 | $3,586,000 | +12.8% | 75,853 | +22.4% | 0.00% | – |
Q1 2021 | $3,178,000 | +81.4% | 61,979 | -5.3% | 0.00% | – |
Q4 2020 | $1,752,000 | +93.0% | 65,416 | +147.3% | 0.00% | – |
Q3 2020 | $908,000 | – | 26,456 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $39,700,000 | 30.52% |
SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $565,858,000 | 4.50% |
Zebra Capital Management LLC | 25,419 | $647,000 | 1.90% |
Alaska Permanent Fund Corp | 2,300,000 | $58,581,000 | 0.84% |
CLARK ESTATES INC/NY | 180,000 | $4,585,000 | 0.79% |
Temasek Holdings (Private) Ltd | 5,602,553 | $142,697,025 | 0.78% |
SECTOR GAMMA AS | 110,223 | $2,807,000 | 0.63% |
Avidity Partners Management LP | 758,211 | $19,312,000 | 0.44% |
New Vernon Capital Holdings II LLC | 14,501 | $369,000 | 0.30% |
DUALITY ADVISERS, LP | 116,415 | $2,965,000 | 0.29% |